Balance Sheet
Cash Flow Statement
Asset Writedowns and ImpairmentCapital ExpendituresCash from Financing ActivitiesCash from Investing ActivitiesCash from OperationsChange in Accured ExpensesChange in CashChange in InventoryChange in ReceivablesChange in TaxesDeferred TaxesDepreciation & Amortization (CF)DivestmentsDividends Paid - CommonExchange Rate EffectFree Cash FlowGains from Investment SecuritiesGains from Sales and DivestituresNet Cash FlowNet IncomeNon-cash ItemsOther Working Capital ChangesSales of Property, Plant and EquipmentShare-based Compensation
Daily Values
Growth Metrics
Income Statement
Others
Ratios

BIO-TECHNE (TECH) Non-cash Items: 2013-2025

  • BIO-TECHNE's Non-cash Items rose 1788.40% to $155.0 million in Q2 2025 from the same period last year, while for Jun 2025 it was $155.0 million, marking a year-over-year increase of 1788.40%. This contributed to the annual value of $155.0 million for FY2025, which is 79.26% down from last year.
  • According to the latest figures from Q2 2025, BIO-TECHNE's Non-cash Items is $155.0 million, which was up 1,788.40% from $8.2 million recorded in Q2 2024.
  • Over the past 5 years, BIO-TECHNE's Non-cash Items peaked at $155.0 million during Q2 2025, and registered a low of $7.1 million during Q2 2021.
  • Its 3-year average for Non-cash Items is $57.3 million, with a median of $8.6 million in 2023.
  • In the last 5 years, BIO-TECHNE's Non-cash Items dropped by 5.01% in 2024 and then spiked by 1,788.40% in 2025.
  • BIO-TECHNE's Non-cash Items (Quarterly) stood at $7.1 million in 2021, then increased by 10.49% to $7.8 million in 2022, then grew by 10.82% to $8.6 million in 2023, then fell by 5.01% to $8.2 million in 2024, then skyrocketed by 1,788.40% to $155.0 million in 2025.
  • Its last three reported values are $155.0 million in Q2 2025, $8.2 million for Q2 2024, and $8.6 million during Q2 2023.